Evidence map›Paper›PMID 41743222›Full record

ArticleFrontiers in pediatrics2026

Testicular regression syndrome in children: a retrospective analysis of diagnostic and laparoscopic findings.

Thuy Nguyen Thi Mai, Khang Do Van

Abstract read
In one paragraph

Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Thuy Nguyen Thi MaiDepartment of Urology, Vietnam National Children's Hospital, Hanoi, Vietnam.
Khang Do VanDepartment of Surgery, Hanoi Medical University, Hanoi, Vietnam.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Testicular regression syndrome (TRS) is a cause of nonpalpable testis resulting from prenatal testicular involution. This study aims to describe clinical, ultrasonographic, and laparoscopic characteristics and surgical management of TRS, and to evaluate the necessity of inguinal exploration following laparoscopy. Materials and methods: A retrospective descriptive study was conducted on boys <16 years who underwent laparoscopic exploration for unilateral intra-abdominal nonpalpable testes at Vietnam National Children's Hospital between January 2021 and October 2025 and were diagnosed intraoperatively with TRS. Data collected included age, laterality, ultrasonographic findings, laparoscopic features, the decision to perform inguinal exploration, and histopathology of nubbin. Contralateral testicular size was measured by ultrasonography and compared with age-matched normal values, with Results: Forty-three patients were included; median age at surgery was 26 months (range 9-156 months), and 32 cases (74.4%) involved the left side. Ultrasonography yielded false-positive findings in 12 cases (27.9%). Contralateral testicular volume was larger than normal in children <24 months (0.86 ± 0.23 vs. 0.44 ± 0.14 mL; Conclusions: Testicular regression syndrome (TRS) is characterized by left-sided predominance and age-dependent compensatory hypertrophy of the contralateral testis. Ultrasonography is unreliable for diagnosis. While inguinal exploration frequently identifies fibrous remnants containing histological markers of regression, the clinical necessity of routine excision remains debated. We advocate for an individualized management approach that balances the benefits of definitive diagnosis against the low risk of malignancy.

Indexed as

inguinal explorationlaparoscopynubbintesticular regression syndromeundescended testis

Identifiers

PMID41743222
PMCPMC12929493

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.